课题基金 / 基金详情

ANTITUMOR AND ANTIVIRAL NUCLEOSIDE ANALOGS

ANTITUMOR AND ANTIVIRAL NUCLEOSIDE ANALOGS
抗肿瘤和抗病毒核苷类似物
批准号:
2088396
负责人:
JIRI ZEMLICKA
金额:
$25.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-07-01 至 1995-12-31

项目摘要

项目成果

JIRI ZEMLICKA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: ( Adapted from Applicant's Abstract). New nucleoside analogues will be prepared and studied as potential antiviral and antitumor agents. These compounds will include: i) Enantiomers of active inhibitors of HIV, adenallene and cytallene. ii) Additional analogues of an allene type including fluoro derivatives and allenediols, iii) spirocyclic analogues of allenes, iv) acetylenic and olefinic acyclic nucleoside analogues and their phosphonates, v) 2'-oxacarbocyclic analogues of nucleosides ("isonucleosides") and vi) triphosphate derivatives of allenes for studies of mechanisms of action of adenallene and cytallene. Antitumor activity and mechanism of action of the active analogues will be studied in vitro and in vivo using murine leukemia L 1210 and a number of other tumor systems including solid tumors. Antiviral effects will be investigated in several assays with DNA and RNA viruses with a particular emphasis on HIV. The appropriate analogues (adenine derivatives) will be tested as substrates for adenosine deaminase.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
METHYLENECYCLOPROPANE ANALOGS AND PRODRUGS FOR HCMV
METHYLENECYCLOPROPANE ANALOGS AND PRODRUGS FOR HCMV
METHYLENECYCLOPROPANE ANALOGS AND PRODRUGS FOR HCMV
METHYLENECYCLOPROPANE ANALOGS AND PRODRUGS FOR HCMV
海外基金